TECHINNOVATION TECH OFFERS

With the global trend of industrial automation, robotic arm technology is being developed and integrated to existing business workflow, increasing labour productivity and operational efficiency. However, current end effectors attached to robotic arm excels in automation tasks of handling homogeneous robust objects but fall short in handling irregular, fragile objects. Current robotic grippers (end effector) lack the finesse and limberness required, limiting their usage in particular areas such as agriculture, F&B, pharmaceutical and logistics. The technology solution developed is a smart soft robotic gripper as a modular end effector that addresses the challenge of handling objects with varying sizes, shapes, and weights, an issue unsolved by traditional robotic grippers. This innovative gripper tool mimics the flexibility and versatility of biological structures like tendrils, enabling an extra dimension of growth and twining capabilities. By wrapping itself securely around objects, the gripper manipulates items gently, minimizing the risk of crushing or damaging them. Its integrated sensors provide real-time contact feedback capabilities, enabling precise monitoring and adaptive control by the robotic system. The technology owner is seeking collaborative partners, such as system integrators or end-users, who are in need and keen to integrate a versatile, adaptive, and gentle handling solution that can operate efficiently in environments where object fragility or irregularity is a key concern.

In a more globalized and interconnected world, logistical management becomes more complex with more demand for real-time tracking of products within the supply chain. With global events potentially disrupting any section of the supply chain, companies within are now required to efficiently provide visibility of the orders while building up resiliency to ensure smooth operation of their services. The technology solution addresses the complexities of modern supply chains by providing a unified solution that integrates multiple products & tools for efficiently managing the logistics and warehouse. The platform uses AI and IoT to deliver real-time visibility, predictive analytics, and automated workflows. This innovation aims to improve efficiency, reduce costs, and enhance sustainability for enterprises within the logistics and warehouse sectors. The technology owner is looking for collaboration partners, who wish to leverage on their data and AI solutions to automate logistical workflow operations and enable data-driven decisions for supply chain optimisation.

Cancer is one of the most deadly diseases worldwide, requiring pathological testing to confirm the diagnosis. With recent advancements in digital pathology, there is a growing demand for AI-based digital pathology diagnostic products to manage and shorten diagnosis time for accurate and targeted treatments. Thyroid cancer is a relatively common type of cancer. The malignancy of thyroid nodules is determined through the pathological examination of cells obtained via Fine Needle Aspiration (FNA) or Core Needle Biopsy (CNB). However, due to the complexities of thyroid nodule pathology, over 30% of patients' biopsy samples are classified as indeterminate, meaning they cannot be definitively diagnosed as benign or malignant. Additional testing, such as Next-Generation Sequencing (NGS) molecular tests are required to provide further clarification. However, the high cost of testing limits patient accessibility. This technology is an AI-powered solution that analyze pathology images obtained through Core Needle Biopsy (CNB), providing diagnostic results for benign or malignant nodules. It offers interpretation and visualization of AI analysis results. This allows for accurate diagnosis of not only the benign(C2) and malignant(C6) cases traditionally identified by pathologists but also indeterminate(C3,C4,C5) cases that were previously challenging to diagnose. This approach ultimately reduces unnecessary surgeries, thereby improving the quality of life for patients. It offers a cost-effective alternative to expensive and less accessible NGS testing, delivering similar diagnostic accuracy without the need for additional tests. The technology owner is seeking partnerships with medical institutions specializing in oncology, including major hospitals and clinical laboratories, pharmceutical and biotechnology companies. 

Maintaining clean air on ships is crucial for the health and well-being of passengers and crew, as well as for the proper functioning of sensitive equipment. Due to the structural specificity of ships and higher reliance on mechanical air conditioning than natural ventilation, addressing indoor air quality issues is particularly important. Advanced air purification solutions would be able to effectively address a range of airborne contaminants, including particulate matter, volatile organic compounds (VOCs), and biological pollutants, ensuring a safer and more pleasant environment on board. A Korean startup has developed an air sterilisation and purification system tailored specifically to the challenges of maritime environments that excels in delivering clean, safe, and compliant air quality solutions. They enhance health and safety, optimise operational efficiency, and contribute to a better overall experience for passengers and crew, while also meeting regulatory requirements and supporting environmental sustainability. The company is seeking collaborators from the maritime and built environment sectors, as well as HVAC and IoT companies, to expand their applications and explore integration of their technologies into existing HVAC systems.

A smart manufacturing and supply chain platform has been developed, enabling seafood processors to automate and digitize their production, quality control, costing, traceability, cold chain, and inventory workflows using tablet computers, sensors, and IoT devices in real-time on the factory floor. This software is a “low-code” web app that can be easily configured for both simple and complex workflows, suitable for small or large production facilities, and adaptable to the wide variety of seafood processes, including live shellfish, fresh and frozen fish, smokehouses, and industrial-scale canneries. The workflow platform includes advanced modules for IoT hardware integration, artificial intelligence, advanced analytics and reporting, a wireless cold-chain sensor, a consumer tracing app, and computer vision for automated inspection. Generative AI is also integrated into the platform, allowing users to “talk to their data” and upload documents to train the large language model. The platform provides value to customers in three core areas: First, the software and AI reduce labor costs by making data collection, management, and reporting more efficient. Second, the software enables real-time process and inventory control, replacing outdated analog paper record-keeping. Third, the software reduces data errors and strengthens traceability, improving compliance with third-party certifications and food safety regulations. Additionally, it includes AI algorithms for yield prediction, anomaly detection, demand forecasting, and drain weight prediction in the fish canning sector.

Plastic recycling plays a crucial role in achieving a sustainable future. Proper sorting of waste plastics is essential, especially in mixed waste streams where various materials are combined. Some types of plastic are not recyclable, and even recyclable ones can be difficult to separate efficiently. Sorting mixed waste streams into different recyclable categories can be time-consuming and labour-intensive, especially for materials with similar appearances, such as different types of plastic. To address these challenges, this technology aims to automate and accurately sort plastic waste, reducing the reliance on manual processing and improving overall plastic recycling efficiency. The technology on offer is a patented artificial intelligence (AI) based material sorting robot that sorts plastic waste accurately. Comprising of a camera, recognition unit and analysis unit, each unit of this system can continuously identify and sort waste plastics and generate information in real time. Blower vacuum adsorption devices are placed within each unit to pick waste in a speedy and accurate manner. This technology effectively reduces the issue of labour shortage in the waste sector, lowers operating costs and contamination rates that hinders recycling efforts. Currently, the technology has been deployed successfully in South Korea to sort polyethylene terephthalate (PET), polyethylene (PE) and polypropylene (PP). The technology owner is interested to work with Singapore waste collection companies on joint development projects to testbed this technology and improve plastic recycling rates.

With the increasing complexity and scale of projects, the need for efficient collaboration and information management has become more apparent, especially in large-scale initiatives. In response, many countries have mandated the use of Building Information Modelling (BIM) to enforce stringent construction project management and document control standards. As a result, BIM has been widely adopted across the industry, demonstrating its significant benefits. To better integrate work processes and connect stakeholders throughout the construction and building lifecycle, a Common Data Environment (CDE) is essential. The CDE provides a single source of truth with ISO 19650 full compliance approach to creating, organizing, and communicating information for project collaboration and lifecycle management of facilities. As a key component of digital transformation, the CDE integrates seamlessly with BIM workflows. It is regarded as one of the pillars of construction digitalization, enhancing BIM's effectiveness by serving as a central repository for collaboration throughout the entire project lifecycle. The technology provider seeks collaboration with construction firms, architects, BIM specialists, IT consultants, and facility managers.

As the customized cosmetics market continues to grow, the demand for cosmetics suitable to an individual's skin condition is increasing. Effective skin diagnosis and management to meet customer needs require total skincare solution products and services that enable continuous and quantitative skin care and management through accurate diagnosis. Currently, customized cosmetics in the market are less accurate in diagnosis and are limited to a small range of formulation permutations. This technology provides a total solution to hyper-personalization of skin care formulations tailored to 40 different skin MBTI conditions from measurement, diagnosis, manufacture, to supply. Based on 98.3% accuracy through a patented skin diagnosis device, a global skin database has been developed which is capable of generating a formulation within 4 minutes. To ensure a complete pipeline solution, the technology extends into manufacturing by having a fully automated patented sterile cosmetic manufacturing equipment and system. The daily production capacity can be supplied in varying quantity of volumes. Through its database and diagnostic technology, it is able to partner ingredient suppliers to formulate sustainable products. The company has also expanded the solution to non-beauty applications including hair care, fragrances and functional foods. The company is looking to partner with B2B customers who is looking to leverage on the various solution packages offered including diagnosis devices, manufacturing automation equipment systems, raw materials and subscription options to begin their journey for a hyper-personalization beauty brand or to further enhance their existing personalization capabilities to establish a stronger brand presence, product differentiation and offerings.

The field of medical aesthetics has witnessed remarkable growth, driven by the increasing demand for non-surgical cosmetic treatments. Patients are increasingly seeking minimally invasive procedures that provide effective results with minimal discomfort, reduced downtime, and fewer side effects. This has spurred the development of advanced technologies such as dermal fillers, botulinum toxin injections, and various energy-based devices to address common concerns like wrinkles, skin laxity, and volume loss. Despite these advancements, traditional needle-based injection methods still present challenges. They can cause discomfort, bruising, and anxiety, which often deter patients from seeking treatment or lead to suboptimal results due to patient hesitation. Additionally, needle-based procedures carry inherent risks, such as infection, uneven distribution of the injected substance, and potential damage to surrounding tissues. To overcome these issues, a laser-guided, needleless drug injection device has been developed. This technology utilizes a 2940nm Er:YAG laser that interacts with water to create internal explosions, generating strong pressure. This pressure converts the drug, sprayed from a nozzle, into a jet form, allowing it to be delivered precisely and evenly into the desired skin layer. The technology enables the rapid injection of large quantities of medication, offering a pain-free, controlled, and efficient alternative to traditional needle-based injections. The technology owner is seeking collaboration with partners in the aesthetics, pharmaceutical, medical laser device manufacturers, and professional medical institutions. The goal is to expand the application of this technology beyond aesthetics, into areas such as drug delivery for vaccines and other therapeutic uses.